Last update 19 Jun 2024

SHR-2002

Overview

Basic Info

Drug Type
Bispecific antibody
Synonyms
SHR 2002, SHR-2002, SHR2002
Target
CD112R x TIGIT
Mechanism
CD112R antagonists(Transmembrane protein PVRIG antagonists), TIGIT inhibitors(T cell immunoglobulin and ITIM domains inhibitors)
Therapeutic Areas
Neoplasms
Active Indication
Advanced cancerNeoplasmsSolid tumor
Inactive Indication-
Originator Organization
Suzhou Suncadia Biopharmaceuticals Co., Ltd.Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Active Organization
Atridia Pty Ltd.Shanghai Hengrui Pharmaceutical Co., Ltd.Shanghai Hengrui Pharmaceutical Co., Ltd.Suzhou Suncadia Biopharmaceuticals Co., Ltd.Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-

Related

2
Clinical Trials associated with SHR-2002
CTR20220004 / RecruitingPhase 1
SHR-2002注射液单药或联合其他抗肿瘤治疗在晚期恶性肿瘤患者中的安全性、耐受性、药代动力学和疗效的I期临床研究
[Translation] A Phase I clinical study on the safety, tolerability, pharmacokinetics and efficacy of SHR-2002 injection alone or in combination with other anti-tumor therapies in patients with advanced malignant tumors
NCT05082545 / CompletedPhase 1
A Phase I Clinical Study on the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of SHR-2002 Injection in Combination With SHR-1316 in Patients With Advanced Malignant Tumors
100 Clinical Results associated with SHR-2002
Login to view more data
100 Translational Medicine associated with SHR-2002
Login to view more data
100 Patents (Medical) associated with SHR-2002
Login to view more data
100 Deals associated with SHR-2002
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced cancerPhase 1
CN
Shanghai Hengrui Pharmaceutical Co., Ltd.
22 Feb 2022
Advanced cancerPhase 1
CN
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
22 Feb 2022
NeoplasmsPhase 1
AU
Atridia Pty Ltd.
23 Nov 2021
Solid tumorIND Approval
CN
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
15 Dec 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free